First Time Loading...

Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.24 DKK 0.49% Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

BIOPOR Price Targets Summary
Bioporto A/S

Wall Street analysts forecast BIOPOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOPOR is 5.1 DKK with a low forecast of 5.05 DKK and a high forecast of 5.25 DKK.

Lowest
Price Target
5.05 DKK
307% Upside
Average
Price Target
5.1 DKK
311% Upside
Highest
Price Target
5.25 DKK
323% Upside
Bioporto A/S Competitors:
Price Targets
LGND
Ligand Pharmaceuticals Inc
69% Upside
BMRN
Biomarin Pharmaceutical Inc
38% Upside
UTHR
United Therapeutics Corp
27% Upside
MRUS
Merus NV
38% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
21% Upside
ALERS
Eurobio Scientific SA
107% Upside
ADAG
Adagene Inc
412% Upside
RCUS
Arcus Biosciences Inc
157% Upside

Revenue
Forecast

Revenue Estimate
Bioporto A/S

For the last 8 years the compound annual growth rate for Bioporto A/S's revenue is 5%. The projected CAGR for the next 1 year is 30%.

5%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioporto A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioporto A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOPOR's stock price target?
Price Target
5.1 DKK

According to Wall Street analysts, the average 1-year price target for BIOPOR is 5.1 DKK with a low forecast of 5.05 DKK and a high forecast of 5.25 DKK.

What is Bioporto A/S's Revenue forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Bioporto A/S's revenue is 5%. The projected CAGR for the next 1 year is 30%.